The company has raised $2.75 million to date from Giza Venture Capital and TRD Instrum.
Cryotherapy solutions company Arbel Medical Ltd. has raised a further $450,000 in its second funding round. The company said it had raised $2.75 million to date from Giza Venture Capital, Ofer Hi-Tech Ventures and TRD Instrum Ltd. (TASE:TRD) and that it would raise further funding from Cleveland-based venture capital fund Bridge Investment Fund LP, bringing the total to $3.5 million. Arbel is conducting trials in Cleveland and is looking at the option of opening an office there, if and when it has sales.
Published by Globes [online], Israel business news - www.globes-online.com - on April 23, 2008
© Copyright of Globes Publisher Itonut (1983) Ltd. 2008